Polymorphisms of some chemokine receptor genes and their ligands are associated with susceptibility and progression of human immunodeficiency virus infection. This study assessed whether these variants are also responsible for susceptibility to infection with human T lymphotropic virus (HTLV) type I. Frequencies of CCR5-D32, CCR2-64I, and SDF-1-3 0 A genotype among 116 HTLV-I-positive and 126 HTLV-I-negative persons of African descent in Jamaica were 1.0%, 14.9%, and 5.4%, respectively. The association of HTLV-I infection with the most common variant, CCR2-64I, was examined in 532 subjects. Thirteen (5.4%) of 241 HTLV-I-negative subjects were homozygous for CCR2-64I, versus 3 (1.0%) of 291 HTLV-I-positive subjects (P ¼ .005). Among HTLV-I carriers, provirus load and antibody titer were not significantly different in persons with CCR2-þ /64I or CCR2-þ /þ . These findings suggest that CCR2-64I, or alleles in linkage disequilibrium with it, may affect the risk of HTLV-I infection in a recessive manner.
Some members of the CC and CXC families of transmembrane chemokine receptors serve as coreceptors for the entry of human immunodeficiency virus (HIV) into host cells [1, 2] . Allelic variants in these genes and their ligands are associated with an altered susceptibility to HIV infection and disease progression [2, 3] . A 32-bp deletion in the CCR5 gene (CCR5-D32) is found in 10% of white persons but is rare (, 2%) among other racial groups [1] [2] [3] . An amino acid change at position 64 in CCR2 (CCR2-64I) is common in all racial groups with allele frequencies of 10% -15% [4] . A single base substitution in the 3 0 untranslated region of stromal-derived factor 1 (SDF-1-3 0 A), a ligand for the T cell-tropic HIV coreceptor CXCR4, is found in 16%-26% of whites, Hispanics, and Asians, 6% of African Americans, and 3% of native Africans [2, 5] . CCR5-D32/D32 homozygosity confers resistance against HIV infection, whereas CCR5-þ/D32 heterozygosity delays HIV disease progression [2] . CCR2-þ /64I heterozygosity and SDF-1-3 0 A/3 0 A homozygosity also are thought to delay HIV disease progression [4, 5] .
Human T lymphotropic virus (HTLV) type I is endemic in southwest Japan, the Caribbean, and parts of Africa [6] . Although HTLV-I and HIV have similar genomic structure and share many biologic properties including T cell tropism, the receptors for HTLV-I entry into host cells remain elusive. A number of cell surface molecules, including tetraspanin CD82, VCAM-1, and hsc-70, play a role in fusion with viral envelope glycoproteins [7, 8] . Although any of these molecules may serve as potential coreceptors, evidence for a functional role as a primary receptor for HTLV-I is lacking. Because chemokine receptors are also used as portals of entry by certain intracellular pathogens other than HIV [9] , it is possible they may play a role in HTLV-I infection.
Methods
Study subjects. Subjects for the present analyses were selected from 2 epidemiologic cohorts in Jamaica. The Food Handlers Study screened .13,000 food service license applicants from 13 parishes for HTLV-I antibody between March 1985 and May 1986 [10] . From this cohort, 214 HTLV-I-positive and 226 age-and sex-matched HTLV-I-negative subjects residing in 3 parishes (Kingston, St. Andrew, and Clarendon) were enrolled in a nested case-control study between January 1987 and April 1998. The Mother-Infant Study screened . 9000 pregnant women for HTLV-I antibody at 2 antenatal clinics in Kingston between January 1989 and August 1990 [11] . In total, 212 HTLV-I-positive and 127 HTLV-I-negative women, similar in age distribution, were enrolled in a prospective follow-up of their offspring.
For the initial analysis of gene frequency, we selected 242 participants (31 men and 211 women) from the Food Handlers Study on the basis of their African ancestry and availability of DNA specimens. For the subsequent analysis of CCR2 polymorphism and HTLV-I infection, 532 subjects were included. In addition to the 242 food handlers, we selected an additional 290 women from the Mother-Infant Study on the basis of their African ancestry and availability of DNA specimens. Because the frequencies of CCR2-64I genotype were similar in both studies, we were able to combine the 2 populations.
Laboratory methods. Peripheral blood samples were cryopreserved and stored at 2 70 C until use. HTLV-I positivity was determined by ELISA (Dupont) and confirmed by Western blot (Cambridge-Biotech). HTLV-I antibody titers were determined by ELISA with the end-point dilution method (Genetic Systems or Cambridge-Biotech).
HTLV-I provirus load was measured by a real-time automated polymerase chain reaction (PCR) method. DNA was prepared from 10 6 viably frozen peripheral blood mononuclear cells (PBMC). In all, 10 mL of DNA (~1 mg) was amplified for 45 cycles with AmpliTaq Gold polymerase with the ABI PRISM sequence detection system and TaqMan PCR reagent (PE Applied Biosystems). Provirus load was normalized by the number of human endogenous retrovirus (ERV)-3 copies to adjust for variation in DNA recovery and amplification efficiency.
The conditions for PCR amplification and the sequencing of the primers for CCR5-D32 [2, 3] , CCR2-64I [4] , and SDF-1-3 0 A [5] genotypes have been described elsewhere. The CCR5-D32 genotype was determined by PCR by using primers 5 0 -CTTCATTACACCTGC-AGCTCTC-3 0 (forward) and 5 0 -CTCACAGCCCAGTGCGACTT-CTTCT-3 0 (reverse), which flank the 32-bp deletion. The CCR2-64I and SDF-1-3 0 A genotypes were determined by PCR amplification followed by restriction fragment-length polymorphism. For CCR2, the primers were CCR2F3 5 0 -ATGCTGTCCACATCTCGTTC-3 0 (forward) and CKR2-1Z 5 0 -GAGCCCACAATGGGAGAGTA-3 0 (reverse). Amplified material was digested with FokI (New England BioLabs) according to the manufacturer's conditions. For SDF-1, the primers were SDF-1-3 0 untranslated region (UTR) 5 0 -CAGT-CAACCTGGGCAAAGCC-3' (forward) and SDF-1-3 0 UTR 5 0 -AGCTTTGGTCCTGAGAGTCC-3 0 (reverse). Amplified product was digested with MspI (New England BioLabs).
In vitro infection of PBMC from 6 study subjects with known CCR2 genotypes (CCR2-þ /þ and CCR2-64I/64I, 3 each) was done as described elsewhere [12] . PBMC were cocultivated with an equal number of lethally radiated (6000 rad) HTLV-I-and HTLV-II-infected cell lines. Previously established HTLV-I-infected T cell lines SP, MT2, and HUT102 and HTLV-II-infected T cell line AI-1050 were grown in C-RPMI supplemented with 10% interleukin (IL)-2 and used for cocultivation [13] . After 24 h, cells were extensively washed and cultured at 10 6 viable cells/mL in C-RPMI, supplemented with 10% IL-2. The culture supernatants were collected at 7-day intervals for 60 days and stored at 270 C until further analysis. The HTLV antigen production in the culture supernatants was determined by use of a p19 Gag antigen capture assay after 60 days (Zepto Metrix).
Statistical analyses. Frequencies of each allele variant by HTLV-I status were compared with the likelihood x 2 or Fisher's exact tests. The odds ratios (ORs) for the association of HTLV-I positivity with the presence of the chemokine receptor variant were calculated with EpiInfo version 6.04 (Centers for Disease Control and Prevention). The 95% confidence intervals were exact where the expected number of observations per cell was , 5. Among HTLV-I carriers, the mean HTLV-I provirus load and anti-HTLV-I titer were compared by the Kruskal-Wallis test. Statistical significance was based on 2-sided tests (P ¼ :05).
Results
Among 242 subjects from the Food Handlers Study included in the analysis of gene frequencies, 5 (2.1%) were CCR5-þ/ D32 and none were CCR5-D32/D32 (table 1). Of the 242 subjects, 22 (9.1%) were SDF-1-þ /3 0 A and 2 (0.8%) were SDF-1-3 0 A/ 3 0 A. Therefore, the allele frequencies of CCR5-D32 and SDF-1-3 0 A were 1.0% (5 of 484) and 5.4% (26 of 484), respectively, which were too low to allow further evaluation with confidence. a Total subjects analyzed for CCR2 genotype are sum of 242 subjects from Food Handlers Study and 290 subjects from Mother-Infant Cohort Study. Total subjects analyzed for CCR5 and SDF-1 genotypes were 242 subjects from Food Handlers Study.
b OR compares frequency of HTLV-I positivity by zygosity by using þ /þ as the referent group. CIs are exact where expected observations are , 5.
The allele frequency of CCR2-64I, on the other hand, was 14.9% (72 of 484); 60 subjects were CCR2-þ /64I and 6 were CCR2-64I/64I.
Because the frequency of the CCR2-64I/64I variant appeared lower among 116 HTLV-I-positive subjects than in 126 HTLV-I-negative subjects (0 vs. 4.8%; P ¼ :06) in the Food Handlers Study, we expanded this analysis to a larger number of subjects. Among 532 subjects included in the analysis of CCR2 genotype and HTLV-I infection from the 2 study populations combined, 16 (3.0%) were CCR2-64I/64I homozygotes (table 1). The frequencies of CCR2-64I/64I homozygosity were 1.0% among HTLV-I-positive subjects and 5.4% among HTLV-I-negative subjects. Persons with CCR2-64I/64I homozygosity were thus significantly less likely to be HTLV-I positive (OR, 0.19; P ¼ :005). CCR2-þ/ 64I heterozygosity, however, did not appear to confer protection against HTLV-I infection (OR, 1.15; P ¼ :47), suggesting a recessive effect.
We next examined whether persons homozygous for CCR2-64I/64I would confer resistance to HTLV-I infection. Table 2 summarizes combined data from all infection experiments. Replication kinetics of cocultivated PBMC revealed initial drop in antigen production (due to residual irradiated cell lines), followed by increase in antigen production around days 40-50 of culture [12] . Lymphocytes from all 3 subjects with CCR2-64I/64I were infected with HTLV-I when cocultivated with the HUT102 cell line. SP and MT2 cell lines also infected lymphocytes of > 1 of these subjects. Furthermore, all lymphocytes became infected with HTLV-II when cocultivated with the AI-1050 cell line. These data provide evidence that lymphocytes from 3 persons with CCR2-64I/64I could be infected with HTLV-I and HTLV-II, as were the lymphocytes from persons with CCR2-þ/þ .
We compared levels of HTLV-I provirus load and antibody titer by CCR2 genotype among HTLV-I-positive subjects in our series. HTLV-I provirus load (log 10 copies/10 5 cells) was similar between persons with CCR2-þ /64I and persons with CCR2-þ /þ (3.19 vs. 3.41, P ¼ :46). Likewise, the mean titer for HTLV-I antibody was not significantly different between subjects with CCR2-þ/64I and those with CCR2-þ/þ (3.62 vs. 3.64 in log 10 ; P ¼ :82). The mean provirus load of 2 persons with CCR2-64I/64I homozygosity appeared slightly lower than the mean provirus load among persons with CCR2-þ /þ (2.89 vs. 3.41; P ¼ :57), but the number of CCR2-64I/64I homozygous subjects was too small to draw any conclusions. None of the HTLV-I carriers in our series had clinical disease associated with HTLV-I; thus, evaluation of an association between CCR2 genotype and disease progression was impossible.
Discussion
The CCR2-64I variant forms heterodimers with CCR5 and CXCR4, which reduce the amount of HIV coreceptors and thus the risk of HIV transmission [14] . In the present investigation, persons with CCR2-64I/64I genotype were significantly less likely to be infected with HTLV-I, although 3 of the 16 CCR2-64I/64I homozygotes were infected with HTLV-I. The results of in vitro infection experiments confirm that both HTLV-I and -II can infect lymphocytes, regardless of the CCR2 genotype (table 2), suggesting that CCR2 is not a required receptor for HTLV infections. The observed incomplete penetrance for the effect of CCR2-64I variant against HTLV-I infection raises the possibility that the blockage of HTLV-I infection likely requires the presence of other cofactors. Gene polymorphisms in linkage disequilibrium with CCR2-64I may be responsible for the observed association. One example may be the CCR-927T variant, which is associated with slow progression of HIV-1 disease [15] . Alternatively, persons with CCR2-64I/64I may clear HTLV-I infection or fail to mount an HTLV-I antibody response.
The observed protective effect of CCR2-64I/64I homozygosity against HTLV-I infection provides an interesting parallel to that observed with CCR5-D32/D32 in the context of HIV infection. Because CCR2-64I is a common variant in all racial groups, a lower frequency of 64I/64I genotype, compared with þ /þ wild type, may be found among HTLV-I carriers in other ethnic groups, including Japanese persons.
In our analysis, we examined the association of CCR2 genotype and the viral pathogenesis by using provirus load and antibody titer as intermediate markers of HTLV-I disease among HTLV-I carriers. No significant difference was found across CCR2 genotype, suggesting that the CCR2-þ /64I heterozygosity is unlikely to be a strong predictor of HTLV-I disease progression in our population.
Of note, the risk of HTLV-I infection in adults is usually higher in women than in men because the virus is more likely to be transmitted by males to females by sexual contact. Our inability to take this into account warrants caution in interpretation of our data from this predominantly female cohort. However, oversampling of female subjects is unlikely to have caused bias in our study, be- 
NOTE. CCR2-þ /þ and 64I/64I denote wild type and homozygote for CCR2-64I variant, respectively. þ , Successful HTLV-I or -II infection of lymphocytes of the study subjects after 60 days of cocultivation with HTLV-positive cell line; ND, not done.
Chemokine Receptor Genes and HTLV-I in Jamaica JID 2002;185 (1 May) cause segregation of chemokine receptor genotype is not sex linked. In addition, frequency of CCR2 variant did not vary across sex in our cohort, nor did the inverse association between CCR2 variant and HTLV-I infection differ by sex. Moreover, we had no reason to believe that CCR2 genotype is associated with survival of the subject in one sex but not the other.
One limitation of the present study was the lack of accurate assessment of exposure to HTLV-I. To confirm or refute our hypothesis, comparisons must be made between HTLV-I carriers and HTLV-I-exposed uninfected persons. Identifying markers for persons who resist this retrovirus would facilitate prevention strategies against this chronic infection and its disease outcomes. The role of chemokine receptor gene polymorphisms in HTLV-I infection and the disease pathogenesis also warrants investigation of this intriguing association in other ethnic groups.
